Beverages - Alcoholic
Compare Stocks
5 / 10Stock Comparison
IPST vs DEO vs STZ vs MGPI vs SAM
Revenue, margins, valuation, and 5-year total return — side by side.
Beverages - Wineries & Distilleries
Beverages - Wineries & Distilleries
Beverages - Wineries & Distilleries
Beverages - Alcoholic
IPST vs DEO vs STZ vs MGPI vs SAM — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Beverages - Alcoholic | Beverages - Wineries & Distilleries | Beverages - Wineries & Distilleries | Beverages - Wineries & Distilleries | Beverages - Alcoholic |
| Market Cap | $57M | $46.38B | $26.05B | $408M | $2.18B |
| Revenue (TTM) | $10M | $37.37B | $9.38B | $521M | $2.09B |
| Net Income (TTM) | $-138M | $5.49B | $1.11B | $-240M | $-61M |
| Gross Margin | 50.8% | 60.0% | 52.0% | 36.4% | 45.2% |
| Operating Margin | -122.1% | 27.9% | 34.5% | -51.2% | -3.8% |
| Forward P/E | — | 17.8x | 12.7x | 12.1x | 20.6x |
| Total Debt | $5M | $24.40B | $12.11B | $267M | $38M |
| Cash & Equiv. | $245K | $2.20B | $68M | $18M | $223M |
IPST vs DEO vs STZ vs MGPI vs SAM — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Nov 24 | May 26 | Return |
|---|---|---|---|
| IP Strategy Holding… (IPST) | 100 | 0.4 | -99.6% |
| Diageo plc (DEO) | 100 | 69.9 | -30.1% |
| Constellation Brand… (STZ) | 100 | 62.4 | -37.6% |
| MGP Ingredients, In… (MGPI) | 100 | 41.2 | -58.8% |
| The Boston Beer Com… (SAM) | 100 | 64.1 | -35.9% |
Price return only. Dividends and distributions are not included.
Quick Verdict: IPST vs DEO vs STZ vs MGPI vs SAM
Each card shows where this stock fits in a portfolio — not just who wins on paper.
IPST is the #2 pick in this set and the best alternative if growth exposure is your priority.
- Rev growth 20.4%, EPS growth 69.8%, 3Y rev CAGR 6.8%
- 20.4% revenue growth vs MGPI's -23.8%
DEO carries the broadest edge in this set and is the clearest fit for income & stability and defensive.
- Dividend streak 12 yrs, beta 0.37, yield 4.9%
- Beta 0.37, yield 4.9%, current ratio 1.63x
- 14.7% margin vs IPST's -13.6%
- 4.9% yield, 12-year raise streak, vs STZ's 2.7%, (2 stocks pay no dividend)
STZ ranks third and is worth considering specifically for long-term compounding.
- 12.6% 10Y total return vs SAM's 32.0%
- Beta 0.26 vs IPST's 2.40
MGPI is the clearest fit if your priority is value.
- Lower P/E (12.1x vs 20.6x)
SAM is the clearest fit if your priority is sleep-well-at-night.
- Lower volatility, beta 0.29, Low D/E 4.5%, current ratio 1.65x
- -15.9% vs IPST's -97.0%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 20.4% revenue growth vs MGPI's -23.8% | |
| Value | Lower P/E (12.1x vs 20.6x) | |
| Quality / Margins | 14.7% margin vs IPST's -13.6% | |
| Stability / Safety | Beta 0.26 vs IPST's 2.40 | |
| Dividends | 4.9% yield, 12-year raise streak, vs STZ's 2.7%, (2 stocks pay no dividend) | |
| Momentum (1Y) | -15.9% vs IPST's -97.0% | |
| Efficiency (ROA) | 14.7% ROA vs IPST's -85.4%, ROIC 9.6% vs -15.4% |
IPST vs DEO vs STZ vs MGPI vs SAM — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
IPST vs DEO vs STZ vs MGPI vs SAM — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
DEO leads in 2 of 6 categories
MGPI leads 1 • SAM leads 1 • STZ leads 1 • IPST leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
DEO leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
DEO is the larger business by revenue, generating $37.4B annually — 3692.5x IPST's $10M. DEO is the more profitable business, keeping 14.7% of every revenue dollar as net income compared to IPST's -13.6%. On growth, IPST holds the edge at +52.5% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $10M | $37.4B | $9.4B | $521M | $2.1B |
| EBITDAEarnings before interest/tax | -$11M | $11.6B | $3.7B | -$249M | $14M |
| Net IncomeAfter-tax profit | -$138M | $5.5B | $1.1B | -$240M | -$61M |
| Free Cash FlowCash after capex | -$15M | $7.7B | $1.8B | $54M | $191M |
| Gross MarginGross profit ÷ Revenue | +50.8% | +60.0% | +52.0% | +36.4% | +45.2% |
| Operating MarginEBIT ÷ Revenue | -122.1% | +27.9% | +34.5% | -51.2% | -3.8% |
| Net MarginNet income ÷ Revenue | -13.6% | +14.7% | +11.8% | -46.0% | -2.9% |
| FCF MarginFCF ÷ Revenue | -152.4% | +20.6% | +18.8% | +10.4% | +9.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | +52.5% | -29.1% | -9.8% | -12.5% | +1.7% |
| EPS Growth (YoY)Latest quarter vs prior year | +54.6% | -24.1% | -15.0% | -44.0% | -7.4% |
Valuation Metrics
MGPI leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 19.7x trailing earnings, DEO trades at a 4% valuation discount to SAM's 20.5x P/E. On an enterprise value basis, SAM's 8.5x EV/EBITDA is more attractive than DEO's 11.3x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $57M | $46.4B | $26.1B | $408M | $2.2B |
| Enterprise ValueMkt cap + debt − cash | $61M | $68.6B | $38.1B | $656M | $2.0B |
| Trailing P/EPrice ÷ TTM EPS | -0.37x | 19.68x | -333.89x | -3.83x | 20.50x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 17.82x | 12.70x | 12.10x | 20.56x |
| PEG RatioP/E ÷ EPS growth rate | — | 2.64x | — | — | — |
| EV / EBITDAEnterprise value multiple | — | 11.33x | 9.37x | — | 8.45x |
| Price / SalesMarket cap ÷ Revenue | 5.61x | 2.29x | 2.55x | 0.76x | 1.04x |
| Price / BookPrice ÷ Book value/share | 0.52x | 3.53x | 3.82x | 0.57x | 2.54x |
| Price / FCFMarket cap ÷ FCF | — | 17.27x | 13.44x | 5.37x | 10.09x |
Profitability & Efficiency
SAM leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
DEO delivers a 54.0% return on equity — every $100 of shareholder capital generates $54 in annual profit, vs $-107 for IPST. SAM carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to DEO's 1.85x. On the Piotroski fundamental quality scale (0–9), SAM scores 7/9 vs MGPI's 4/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -106.9% | +54.0% | +13.9% | -32.1% | -7.3% |
| ROA (TTM)Return on assets | -85.4% | +14.7% | +5.1% | -19.1% | -5.0% |
| ROICReturn on invested capital | -15.4% | +9.6% | +13.0% | -6.7% | +15.5% |
| ROCEReturn on capital employed | -21.7% | +11.7% | +18.0% | -8.1% | +14.8% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 5 | 5 | 4 | 7 |
| Debt / EquityFinancial leverage | 0.05x | 1.85x | 1.70x | 0.37x | 0.04x |
| Net DebtTotal debt minus cash | $4M | $22.2B | $12.0B | $248M | -$186M |
| Cash & Equiv.Liquid assets | $245,282 | $2.2B | $68M | $18M | $223M |
| Total DebtShort + long-term debt | $5M | $24.4B | $12.1B | $267M | $38M |
| Interest CoverageEBIT ÷ Interest expense | 143.02x | 5.71x | 5.47x | -40.23x | — |
Total Returns (Dividends Reinvested)
STZ leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in STZ five years ago would be worth $6,992 today (with dividends reinvested), compared to $43 for IPST. Over the past 12 months, SAM leads with a -15.9% total return vs IPST's -97.0%. The 3-year compound annual growth rate (CAGR) favors STZ at -10.8% vs IPST's -83.7% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -82.7% | -3.3% | +7.9% | -20.3% | +1.5% |
| 1-Year ReturnPast 12 months | -97.0% | -25.1% | -18.7% | -38.0% | -15.9% |
| 3-Year ReturnCumulative with dividends | -99.6% | -49.3% | -29.0% | -79.8% | -35.0% |
| 5-Year ReturnCumulative with dividends | -99.6% | -43.9% | -30.1% | -66.0% | -81.8% |
| 10-Year ReturnCumulative with dividends | -99.6% | +10.0% | +12.6% | -17.3% | +32.0% |
| CAGR (3Y)Annualised 3-year return | -83.7% | -20.3% | -10.8% | -41.3% | -13.4% |
Risk & Volatility
Evenly matched — STZ and SAM each lead in 1 of 2 comparable metrics.
Risk & Volatility
STZ is the less volatile stock with a 0.26 beta — it tends to amplify market swings less than IPST's 2.40 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. SAM currently trades 76.7% from its 52-week high vs IPST's 1.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.40x | 0.37x | 0.26x | 0.63x | 0.29x |
| 52-Week HighHighest price in past year | $532.00 | $116.69 | $196.91 | $34.99 | $264.46 |
| 52-Week LowLowest price in past year | $1.41 | $72.46 | $126.45 | $16.45 | $185.34 |
| % of 52W HighCurrent price vs 52-week peak | +1.1% | +71.5% | +76.3% | +54.6% | +76.7% |
| RSI (14)Momentum oscillator 0–100 | 42.1 | 63.5 | 45.9 | 47.6 | 28.7 |
| Avg Volume (50D)Average daily shares traded | 224K | 1.8M | 1.8M | 279K | 199K |
Analyst Outlook
DEO leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: DEO as "Hold", STZ as "Buy", MGPI as "Buy", SAM as "Hold". Consensus price targets imply 51.9% upside for MGPI (target: $29) vs 16.9% for STZ (target: $176). For income investors, DEO offers the higher dividend yield at 4.95% vs MGPI's 2.53%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Hold | Buy | Buy | Hold |
| Price TargetConsensus 12-month target | — | $124.00 | $175.70 | $29.00 | $246.86 |
| # AnalystsCovering analysts | — | 35 | 46 | 14 | 31 |
| Dividend YieldAnnual dividend ÷ price | — | +4.9% | +2.7% | +2.5% | — |
| Dividend StreakConsecutive years of raises | — | 12 | 4 | 2 | 0 |
| Dividend / ShareAnnual DPS | — | $4.13 | $4.03 | $0.48 | — |
| Buyback YieldShare repurchases ÷ mkt cap | +0.0% | 0.0% | +4.3% | +0.3% | +9.4% |
DEO leads in 2 of 6 categories (Income & Cash Flow, Analyst Outlook). MGPI leads in 1 (Valuation Metrics). 1 tied.
IPST vs DEO vs STZ vs MGPI vs SAM: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is IPST or DEO or STZ or MGPI or SAM a better buy right now?
For growth investors, IP Strategy Holdings, Inc.
(IPST) is the stronger pick with 20. 4% revenue growth year-over-year, versus -23. 8% for MGP Ingredients, Inc. (MGPI). Diageo plc (DEO) offers the better valuation at 19. 7x trailing P/E (17. 8x forward), making it the more compelling value choice. Analysts rate Constellation Brands, Inc. (STZ) a "Buy" — based on 46 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — IPST or DEO or STZ or MGPI or SAM?
On trailing P/E, Diageo plc (DEO) is the cheapest at 19.
7x versus The Boston Beer Company, Inc. at 20. 5x. On forward P/E, MGP Ingredients, Inc. is actually cheaper at 12. 1x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — IPST or DEO or STZ or MGPI or SAM?
Over the past 5 years, Constellation Brands, Inc.
(STZ) delivered a total return of -30. 1%, compared to -99. 6% for IP Strategy Holdings, Inc. (IPST). Over 10 years, the gap is even starker: SAM returned +32. 0% versus IPST's -99. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — IPST or DEO or STZ or MGPI or SAM?
By beta (market sensitivity over 5 years), Constellation Brands, Inc.
(STZ) is the lower-risk stock at 0. 26β versus IP Strategy Holdings, Inc. 's 2. 40β — meaning IPST is approximately 816% more volatile than STZ relative to the S&P 500. On balance sheet safety, The Boston Beer Company, Inc. (SAM) carries a lower debt/equity ratio of 4% versus 185% for Diageo plc — giving it more financial flexibility in a downturn.
05Which is growing faster — IPST or DEO or STZ or MGPI or SAM?
By revenue growth (latest reported year), IP Strategy Holdings, Inc.
(IPST) is pulling ahead at 20. 4% versus -23. 8% for MGP Ingredients, Inc. (MGPI). On earnings-per-share growth, the picture is similar: The Boston Beer Company, Inc. grew EPS 95. 5% year-over-year, compared to -419. 9% for MGP Ingredients, Inc.. Over a 3-year CAGR, DEO leads at 9. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — IPST or DEO or STZ or MGPI or SAM?
Diageo plc (DEO) is the more profitable company, earning 11.
6% net margin versus -1360. 9% for IP Strategy Holdings, Inc. — meaning it keeps 11. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: STZ leads at 35. 5% versus -122. 1% for IPST. At the gross margin level — before operating expenses — DEO leads at 60. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is IPST or DEO or STZ or MGPI or SAM more undervalued right now?
On forward earnings alone, MGP Ingredients, Inc.
(MGPI) trades at 12. 1x forward P/E versus 20. 6x for The Boston Beer Company, Inc. — 8. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for MGPI: 51. 9% to $29. 00.
08Which pays a better dividend — IPST or DEO or STZ or MGPI or SAM?
In this comparison, DEO (4.
9% yield), STZ (2. 7% yield), MGPI (2. 5% yield) pay a dividend. IPST, SAM do not pay a meaningful dividend and should not be held primarily for income.
09Is IPST or DEO or STZ or MGPI or SAM better for a retirement portfolio?
For long-horizon retirement investors, Constellation Brands, Inc.
(STZ) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 26), 2. 7% yield). IP Strategy Holdings, Inc. (IPST) carries a higher beta of 2. 40 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (STZ: +12. 6%, IPST: -99. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between IPST and DEO and STZ and MGPI and SAM?
Both stocks operate in the Consumer Defensive sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: IPST is a small-cap high-growth stock; DEO is a mid-cap income-oriented stock; STZ is a mid-cap quality compounder stock; MGPI is a small-cap quality compounder stock; SAM is a small-cap quality compounder stock. DEO, STZ, MGPI pay a dividend while IPST, SAM do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.